Skip to main content
Premium Trial:

Request an Annual Quote

Expression Pathology Licenses Harvard’s AQUA Technology for Protein Quantification

NEW YORK (GenomeWeb News) - Expression Pathology said last week that it has licensed the patent rights to the AQUA protein quantification technology from Harvard University.
AQUA, a shortened form of “absolute quantification,” uses labeled peptide standards “to achieve absolute quantitation of target proteins in biological samples by mass spectrometry,” Expression Pathology said in a statement.
The company said it will combine AQUA with its own technologies for extracting proteins from formalin-fixed, paraffin-embedded tissues to develop new research and diagnostic applications.
Financial terms of the licensing agreement were not disclosed.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.